Stephens Investment Management Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.2M Buy
723,451
+8,750
+1% +$744K 0.61% 80
2026
Q1
$61.6M Sell
714,701
-2,622
-0.4% -$235K 0.84% 46
2025
Q4
$62.6M Sell
717,323
-737
-0.1% -$55.9K 0.82% 53
2025
Q3
$41.1M Buy
718,060
+69,486
+11% +$4M 0.53% 82
2025
Q2
$38.3M Buy
648,574
+3,517
+0.5% +$227K 0.51% 80
2025
Q1
$47.2M Buy
645,057
+67,687
+12% +$5.59M 0.68% 59
2024
Q4
$47.8M Sell
577,370
-124,490
-18% -$9.82M 0.64% 66
2024
Q3
$50.2M Buy
701,860
+20,946
+3% +$1.48M 0.69% 63
2024
Q2
$46.6M Sell
680,914
-52,157
-7% -$3.12M 0.65% 67
2024
Q1
$39.3M Sell
733,071
-1,078
-0.1% -$58K 0.52% 87
2023
Q4
$39.1M Buy
734,149
+116,575
+19% +$5.68M 0.57% 82
2023
Q3
$30.7M Buy
+617,574
New +$34.5M 0.5% 90

Other funds holding GMED

Stephens Investment Management Group's GMED Position: Q2 2026 in Review

Stephens Investment Management Group increased its Globus Medical (GMED) stake by 1.2% in Q2 2026, buying an estimated $744K and bringing the position to 723,451 shares worth $57.2M. The position accounts for 0.61% of the portfolio, ranked #80.

Stephens Investment Management Group first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $62.6M in Q4 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Stephens Investment Management Group held 723,451 shares of Globus Medical worth $57.2M as of Q2 2026.
  • Stephens Investment Management Group bought 8,750 Globus Medical shares in Q2 2026, an estimated $744K.
  • Globus Medical made up 0.61% of Stephens Investment Management Group's portfolio in Q2 2026, its #80 holding.
  • Stephens Investment Management Group first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
  • Stephens Investment Management Group's Globus Medical position peaked at $62.6M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Stephens Investment Management Group's 13F filing for Q2 2026, filed 29 Jul 2026.